Susumu Yamaki

USPTO Granted Patents = 15 (Patent Applications = 3)

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 57(Granted Patents)

Location History:

Chuo-ku, JP (2014 - 2017)
Tokyo, JP (2012 - 2024)

Company Filing History:

Takeda Pharmaceutical Company Limited

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441691 - Bicyclic 1,4-diazepanones and therapeutic uses thereof (2025-10-14),

2. 11981644 - Bicyclic 1,4-diazepanones and therapeutic uses thereof (2024-05-14),

3. 11479561 - Tetrahydroisoquinoline derivatives (2022-10-25),

4. 10774082 - Quinazoline compound (2020-09-15),

5. 10689393 - Tetrahydroisoquinoline derivatives (2020-06-23),

6. 10556906 - Quinazoline compound (2020-02-11),

7. 10259821 - Tetrahydroisoquinoline derivatives (2019-04-16),

8. 9969709 - Guanidinobenzoic acid ester compound (2018-05-15),

9. 9914741 - Tetrahydroisoquinoline derivatives (2018-03-13),

10. 9556160 - Guanidine compound (2017-01-31),

11. 9199927 - Guanidinobenzoic acid compound (2015-12-01),

12. 9051283 - Guanidine compound (2015-06-09),

13. 8802679 - Glycine compound (2014-08-12),

14. 8716470 - Guanidine compound (2014-05-06),

15. 8263607 - 1-substituted tetrahydroisoquinoline compound (2012-09-11),

Title: The Innovative Contributions of Susumu Yamaki

Introduction

Susumu Yamaki is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, he has made remarkable advancements in the treatment of various diseases and disorders.

Latest Patents

Yamaki's latest patents include groundbreaking compounds such as bicyclic 1,4-diazepanones, which have therapeutic uses. These compounds are designed to treat diseases responsive to the modulation of the contractility of the skeletal sarcomere. Additionally, he has developed novel tetrahydroisoquinoline derivative compounds that serve as active ingredients in pharmaceutical compositions aimed at preventing or treating neuromuscular disorders and other related conditions.

Career Highlights

Throughout his career, Susumu Yamaki has worked with notable companies, including Astellas Pharma GmbH and Cytokinetics, Inc. His work has focused on innovative solutions that address critical health issues, particularly those affecting muscle function and contractility.

Collaborations

Yamaki has collaborated with esteemed colleagues such as Bradley Paul Morgan and Scott E Collibee. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.

Conclusion

Susumu Yamaki's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to innovation and improving health outcomes

This text is generated by artificial intelligence and may not be accurate.